Zoetis | ZTS - Debt


Zoetis reported $9.24B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
AbbVie USD 72.86B 5.36B Mar/2026
Align Technology USD 116.04M 1.6M Mar/2026
Bayer EUR 36.45B 2.93B Dec/2025
Bristol-Myers Squibb USD 46.43B 711M Mar/2026
Charles River Laboratories USD 3.06B 485.84M Mar/2026
Coherus Biosciences USD 294.92M 1.25M Mar/2025
Dentsply International USD 2.33B 137M Mar/2026
Eli Lilly USD 43.37B 867M Mar/2026
Henry Schein USD 3.81B 64M Jun/2026
Idexx Laboratories USD 1.1B 9.37M Jun/2026
Illumina USD 2.54B 9M Mar/2026
IQVIA Holdings USD 16.24B 408M Jun/2026
J&J USD 54.99B 7.05B Mar/2026
Laboratory Of America USD 7.24B 714.6M Mar/2026
Merck USD 49.12B 222M Mar/2026
Neogen USD 793.7M 400K Mar/2026
Pacira USD 363.12M 4.53M Jun/2026
Perrigo USD 3.63B 7.7M Mar/2026
Pfizer USD 63.19B 536M Jun/2026
Phibro Animal Health USD 474.17M 730K Sep/2024
Quest Diagnostics USD 6.41B 179M Mar/2026
Sanofi EUR 23.58B 3.56B Jun/2026
Sanofi EUR 20.02B 1.73B Mar/2026
Zoetis USD 9.24B 0 Mar/2026